Found 5 matching trials
Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion
PHASE1Primary Objective:
* Assess the safety of SAR342434 and Humalog when used ...
Location
Investigational Site Number 840002
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine
PHASE3Primary Objective:
To demonstrate non-inferiority of SAR342434 versus Huma...
Location
Investigational Site Number 840217
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
PHASE3Primary Objective:
To demonstrate non-inferiority of SAR342434 versus Huma...
Location
Investigational Site Number 840049
A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes
PHASE1Primary Objective:
To compare exposure and activity of SAR342434 to US-app...
Location
Sanofi Administrative Office
A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes
PHASE1Primary Objective:
To demonstrate bioequivalence between insulin lispro gi...
Location
Investigational Site Number 2760001